{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:45:06Z","timestamp":1792856706035,"version":"4.5.0"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006742","name":"CESPU","doi-asserted-by":"publisher","award":["TramTap-CESPU-2016"],"award-info":[{"award-number":["TramTap-CESPU-2016"]}],"id":[{"id":"10.13039\/501100006742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006742","name":"CESPU","doi-asserted-by":"publisher","award":["ChronicTramTap_CESPU_2017"],"award-info":[{"award-number":["ChronicTramTap_CESPU_2017"]}],"id":[{"id":"10.13039\/501100006742","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Norte Portugal Regional Operational Programme (NORTE 2020)","award":["NORTE-01-0145-FEDER-000024"],"award-info":[{"award-number":["NORTE-01-0145-FEDER-000024"]}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["IF\/01147\/2013"],"award-info":[{"award-number":["IF\/01147\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Forensic and Legal Medicine"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jflm.2018.12.005","type":"journal-article","created":{"date-parts":[[2018,12,19]],"date-time":"2018-12-19T03:24:38Z","timestamp":1545189878000},"page":"128-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Metabolism and metabolomics of opiates: A long way of forensic implications to unravel"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7430-6297","authenticated-orcid":false,"given":"Ricardo Jorge","family":"Dinis-Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib1","first-page":"219","article-title":"Omics-based biomarkers: current status and potential use in the clinic","volume":"74","author":"Quezada","year":"2017","journal-title":"Bol Med Hosp Infant Mex"},{"issue":"7","key":"10.1016\/j.jflm.2018.12.005_bib2","first-page":"594","article-title":"The emerging field of lipidomics","volume":"4","author":"Wenk","year":"2005"},{"key":"10.1016\/j.jflm.2018.12.005_bib3","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3389\/fimmu.2017.01839","article-title":"Transcriptomics in human challenge models","volume":"8","author":"Barton","year":"2017","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.jflm.2018.12.005_bib4","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jat.2874","article-title":"Review: toxicometabolomics","volume":"33","author":"Bouhifd","year":"2013","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.jflm.2018.12.005_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.pharmtox.48.113006.094715","article-title":"Metabolomics: a global biochemical approach to drug response and disease","volume":"48","author":"Kaddurah-Daouk","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dmpk.2015.10.002","article-title":"Application of metabolomics to toxicology of drugs of abuse: a mini review of metabolomics approach to acute and chronic toxicity studies","volume":"31","author":"Zaitsu","year":"2016","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib7","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00204-010-0609-6","article-title":"The role of metabolites and metabolomics in clinically applicable biomarkers of disease","volume":"85","author":"Mamas","year":"2011","journal-title":"Arch Toxicol"},{"issue":"32","key":"10.1016\/j.jflm.2018.12.005_bib8","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1002\/anie.200905579","article-title":"Targeted metabolomics for biomarker discovery","volume":"49","author":"Griffiths","year":"2010","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib9","doi-asserted-by":"crossref","first-page":"pyv096","DOI":"10.1093\/ijnp\/pyv096","article-title":"Omics-based biomarkers: application of metabolomics in neuropsychiatric disorders","volume":"19","author":"Sethi","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1365-2125.2005.02435.x","article-title":"Biomarkers and surrogate endpoints","volume":"59","author":"Aronson","year":"2005","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib11","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1097\/COH.0b013e32833ed177","article-title":"What are biomarkers?","volume":"5","author":"Strimbu","year":"2010","journal-title":"Curr Opin HIV AIDS"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib12","first-page":"39","article-title":"Biomarker based clinical trial design","volume":"3","author":"Simon","year":"2014","journal-title":"Chin Clin Oncol"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201100153","article-title":"Genomic biomarkers in predictive medicine: an interim analysis","volume":"3","author":"Simon","year":"2011","journal-title":"EMBO Mol Med"},{"issue":"4064","key":"10.1016\/j.jflm.2018.12.005_bib14","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.178.4064.984","article-title":"Blood-brain barrier: penetration of morphine, codeine, heroin, and methadone after carotid injection","volume":"178","author":"Oldendorf","year":"1972","journal-title":"Science"},{"issue":"9141","key":"10.1016\/j.jflm.2018.12.005_bib15","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0140-6736(98)07115-3","article-title":"The discovery of heroin","volume":"352","author":"Sneader","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jflm.2018.12.005_bib16","series-title":"World Drug Report 2018 - Executive Summary Conclusions and Policy Implications","author":"United Nations Office on Drugs and Crime","year":"2018"},{"issue":"9566","key":"10.1016\/j.jflm.2018.12.005_bib17","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"Nutt","year":"2007","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archinte.1967.00300010021004","article-title":"Heroin addiction--a metabolic disease","volume":"120","author":"Dole","year":"1967","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib19","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/jat\/21.5.346","article-title":"Morphine, morphine-3-glucuronide, morphine-6-glucuronide, and 6-monoacetylmorphine determined by means of atmospheric pressure chemical ionization-mass spectrometry-liquid chromatography in body fluids of heroin victims","volume":"21","author":"Bogusz","year":"1997","journal-title":"J Anal Toxicol"},{"issue":"1-2","key":"10.1016\/j.jflm.2018.12.005_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0378-4347(97)00384-8","article-title":"Determination of morphine and its 3- and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry","volume":"703","author":"Bogusz","year":"1997","journal-title":"J Chromatogr B Biomed Sci Appl"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib21","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/jat\/9.3.134","article-title":"Detection of O6-monoacetylmorphine in urine samples by GC\/MS as evidence for heroin use","volume":"9","author":"Fehn","year":"1985","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/15.1.1","article-title":"Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times","volume":"15","author":"Cone","year":"1991","journal-title":"J Anal Toxicol"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/jat\/15.4.161","article-title":"Forensic drug testing for opiates, III. Urinary excretion rates of morphine and codeine following codeine administration","volume":"15","author":"Cone","year":"1991","journal-title":"J Anal Toxicol"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jat\/15.2.49","article-title":"Forensic drug testing for opiates. II. Metabolism and excretion rate of morphine in humans after morphine administration","volume":"15","author":"Mitchell","year":"1991","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.jflm.2018.12.005_bib25","series-title":"Opioids in Medicine: A Comprehensive Review on the Mode of Action and the Use of Analgesics in Different Clinical Pain States","year":"2008"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/1874473711205040003","article-title":"Clinical and forensic signs related to opioids abuse","volume":"5","author":"Dinis-Oliveira","year":"2012","journal-title":"Curr Drug Abuse Rev"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02466781","article-title":"Determination of the five major opium alkaloids by reversed-phase high-performance liquid chromatography on a base-deactivated stationary phase","volume":"47","author":"Krenn","year":"1998","journal-title":"Chromatographia"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib28","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/np0496643","article-title":"Comparative qualitative and quantitative determination of alkaloids in narcotic and condiment Papaver somniferum cultivars","volume":"68","author":"Frick","year":"2005","journal-title":"J Nat Prod"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0031-6997(25)06637-2","article-title":"Pharmacology of opioids","volume":"35","author":"Martin","year":"1983","journal-title":"Pharmacol Rev"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib30","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/02791072.2016.1207826","article-title":"The textures of heroin: user perspectives on \"black tar\" and powder heroin in two U.S. Cities","volume":"48","author":"Mars","year":"2016","journal-title":"J Psychoact Drugs"},{"key":"10.1016\/j.jflm.2018.12.005_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1477-7517-8-3","article-title":"Chasing the dragon - characterizing cases of leukoencephalopathy associated with heroin inhalation in British Columbia","volume":"8","author":"Buxton","year":"2011","journal-title":"Harm Reduct J"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.drugpo.2008.08.003","article-title":"Heroin in brown, black and white: structural factors and medical consequences in the US heroin market","volume":"20","author":"Ciccarone","year":"2009","journal-title":"Int J Drug Pol"},{"issue":"0","key":"10.1016\/j.jflm.2018.12.005_bib33","first-page":"123","article-title":"Ring C-bridged derivatives of thebaine and oripavine","volume":"8","author":"Lewis","year":"1973","journal-title":"Adv Biochem Psychopharmacol"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib34","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/jf60206a022","article-title":"Morphine and codeine in poppy seed","volume":"24","author":"Grove","year":"1976","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.jflm.2018.12.005_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.forsciint.2014.04.042","article-title":"Morphine and codeine concentrations in human urine following controlled poppy seeds administration of known opiate content","volume":"241","author":"Smith","year":"2014","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/FTD.0b013e3181c0eee0","article-title":"Poppy seed foods and opiate drug testing--where are we today?","volume":"32","author":"Lachenmeier","year":"2010","journal-title":"Ther Drug Monit"},{"issue":"11","key":"10.1016\/j.jflm.2018.12.005_bib37","first-page":"302","article-title":"Psychotropic drugs. IV. The morphinan alkaloid content of Papaver somniferum and Papaver bracteatum","volume":"60","author":"Brenneisen","year":"1985","journal-title":"Pharm Acta Helv"},{"issue":"Suppl 1","key":"10.1016\/j.jflm.2018.12.005_bib38","doi-asserted-by":"crossref","first-page":"S416","DOI":"10.1016\/j.legalmed.2009.03.002","article-title":"Effect of poppy seed consummation on the positive results of opiates screening in biological samples","volume":"11","author":"Jankovicova","year":"2009","journal-title":"Leg Med (Tokyo)"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-3565(25)32246-9","article-title":"Hydrolysis of diacetylmorphine (heroin) by human serum cholinesterase","volume":"215","author":"Lockridge","year":"1980","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1139\/y78-105","article-title":"Spontaneous hydrolysis of heroin in buffered solution","volume":"56","author":"Smith","year":"1978","journal-title":"Can J Physiol Pharmacol"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib41","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1111\/j.1476-5381.2010.00700.x","article-title":"Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin","volume":"160","author":"Hatfield","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.toxlet.2014.10.026","article-title":"Contribution of human esterases to the metabolism of selected drugs of abuse","volume":"232","author":"Meyer","year":"2015","journal-title":"Toxicol Lett"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib43","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0091-3057(90)90168-H","article-title":"Selective D1 and D2 dopamine antagonists decrease response rates of food-maintained behavior and reduce the discriminative stimulus produced by heroin","volume":"35","author":"Corrigall","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"issue":"Suppl 1","key":"10.1016\/j.jflm.2018.12.005_bib44","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0024-3205(83)90616-1","article-title":"Evidence from opiate binding studies that heroin acts through its metabolites","volume":"33","author":"Inturrisi","year":"1983","journal-title":"Life Sci"},{"issue":"19","key":"10.1016\/j.jflm.2018.12.005_bib45","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJM198405103101902","article-title":"The pharmacokinetics of heroin in patients with chronic pain","volume":"310","author":"Inturrisi","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jflm.2018.12.005_bib46","first-page":"25","article-title":"Metabolism of heroin and its pharmacologic implications","volume":"17","author":"Way","year":"1965","journal-title":"Bull Narc"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib47","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/bph.12305","article-title":"Levels of heroin and its metabolites in blood and brain extracellular fluid after i.v. heroin administration to freely moving rats","volume":"170","author":"Gottas","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib48","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0022-3565(25)21180-6","article-title":"Metabolism of cocaine and heroin is catalyzed by the same human liver carboxylesterases","volume":"279","author":"Kamendulis","year":"1996","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib49","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1046\/j.1440-1681.1999.03090.x","article-title":"Human erythrocyte but not brain acetylcholinesterase hydrolyses heroin to morphine","volume":"26","author":"Salmon","year":"1999","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"9","key":"10.1016\/j.jflm.2018.12.005_bib50","first-page":"1089","article-title":"Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs","volume":"25","author":"Brzezinski","year":"1997","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib51","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1742-1241.2000.tb11929.x","article-title":"Codeine analgesia is due to codeine-6-glucuronide, not morphine","volume":"54","author":"Vree","year":"2000","journal-title":"Int J Clin Pract"},{"issue":"12","key":"10.1016\/j.jflm.2018.12.005_bib52","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/0049825021000017911","article-title":"Comparative biotransformation of morphine, codeine and pholcodine in rat hepatocytes: identification of a novel metabolite of pholcodine","volume":"32","author":"Jairaj","year":"2002","journal-title":"Xenobiotica"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib53","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3109\/15360288.2014.997854","article-title":"CYP2D6 phenotype-specific codeine population pharmacokinetics","volume":"29","author":"Linares","year":"2015","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib54","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1090-3801(97)90103-8","article-title":"Analgesic effects of codeine-6-glucuronide after intravenous administration","volume":"1","author":"Srinivasan","year":"1997","journal-title":"Eur J Pain"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib55","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002280050247","article-title":"Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes","volume":"52","author":"Yue","year":"1997","journal-title":"Eur J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.jflm.2018.12.005_bib56","first-page":"1080","article-title":"Codeine is a prodrug--the active agent is morphine","volume":"120","author":"Haavik","year":"2000","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib57","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1093\/bja\/aeu186","article-title":"Morphine-6-glucuronide is responsible for the analgesic effect after morphine administration: a quantitative review of morphine, morphine-6-glucuronide, and morphine-3-glucuronide","volume":"113","author":"Klimas","year":"2014","journal-title":"Br J Anaesth"},{"issue":"1 Pt 2","key":"10.1016\/j.jflm.2018.12.005_bib58","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1399-6576.1997.tb04625.x","article-title":"Morphine metabolites","volume":"41","author":"Christrup","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-011-9274-6","article-title":"Morphine metabolism, transport and brain disposition","volume":"27","author":"De Gregori","year":"2012","journal-title":"Metab Brain Dis"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib60","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/aps.2016.157","article-title":"The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants","volume":"38","author":"Yang","year":"2017","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-3565(25)20832-1","article-title":"Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite","volume":"251","author":"Paul","year":"1989","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0014-2999(91)90199-Z","article-title":"Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide","volume":"193","author":"Gong","year":"1991","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.lfs.2014.06.010","article-title":"Morphine glucuronidation increases its analgesic effect in Guinea pigs","volume":"109","author":"Oliveira","year":"2014","journal-title":"Life Sci"},{"issue":"9","key":"10.1016\/j.jflm.2018.12.005_bib64","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/bmc.3158","article-title":"Quantification of morphine and its major metabolites M3G and M6G in antemortem and postmortem samples","volume":"28","author":"Oliveira","year":"2014","journal-title":"Biomed Chromatogr"},{"issue":"21","key":"10.1016\/j.jflm.2018.12.005_bib65","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/0024-3205(88)90479-1","article-title":"Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats","volume":"43","author":"Abbott","year":"1988","journal-title":"Life Sci"},{"issue":"10","key":"10.1016\/j.jflm.2018.12.005_bib66","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0024-3205(95)00010-4","article-title":"Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes","volume":"56","author":"Mignat","year":"1995","journal-title":"Life Sci"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib67","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000542-200504000-00018","article-title":"Randomized, double-blind study of the analgesic efficacy of morphine-6-glucuronide versus morphine sulfate for postoperative pain in major surgery","volume":"102","author":"Hanna","year":"2005","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib68","first-page":"145","article-title":"Respiratory depression following morphine and morphine-6-glucuronide in normal subjects","volume":"40","author":"Thompson","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jflm.2018.12.005_bib69","article-title":"Prolonged central apnoea after intravenous morphine administration in a 12-year-old male with a UGT1A1 loss-of-function polymorphism","author":"Toce","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib70","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/pme.12314","article-title":"Genetic profile and cancer-related pain: a tale from two outlier cases with bone metastatic disease","volume":"15","author":"Oliveira","year":"2014","journal-title":"Pain Med"},{"issue":"19","key":"10.1016\/j.jflm.2018.12.005_bib71","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/0006-2952(85)90728-2","article-title":"Distribution of glucuronidation capacity (1-naphthol and morphine) along the rat intestine","volume":"34","author":"Koster","year":"1985","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib72","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1038\/s41598-018-21915-8","article-title":"Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib73","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3565(25)30046-7","article-title":"Urinary excretion of morphine and its metabolites in morphine-dependent subjects","volume":"192","author":"Yeh","year":"1975","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"9","key":"10.1016\/j.jflm.2018.12.005_bib74","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1002\/jps.2600660921","article-title":"Isolation and identification of morphine 3- and 6-glucuronides, morphine 3,6-diglucuronide, morphine 3-ethereal sulfate, normorphine, and normorphine 6-glucuronide as morphine metabolites in humans","volume":"66","author":"Yeh","year":"1977","journal-title":"J Pharmacol Sci"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib75","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/0049825031000121608","article-title":"Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes","volume":"33","author":"Projean","year":"2003","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib76","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jps.2600680205","article-title":"Isolation and identification of morphine n-oxide alpha- and beta-dihydromorphines, beta- or gamma-isomorphine, and hydroxylated morphine as morphine metabolites in several mammalian species","volume":"68","author":"Yeh","year":"1979","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.jflm.2018.12.005_bib77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0022-3565(25)26785-4","article-title":"Studies on the enzymatic n- and o-demethylation of narcotic analgesics and evidence for the formation of codeine from morphine in rats and dogs","volume":"144","author":"Elison","year":"1964","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib78","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0090-9556(25)05980-X","article-title":"Biotransformation of morphine to dihydromorphinone and normorphine in the mouse, rat, rabbit, Guinea pig, cat, dog, and monkey","volume":"5","author":"Yeh","year":"1977","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib79","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.71","article-title":"Detection of morphine-3-sulfate and morphine-6-sulfate in human urine and plasma, and formation in liver cytosol","volume":"2","author":"Andersson","year":"2014","journal-title":"Pharmacol Res Perspect"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib80","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0022-3565(25)12528-7","article-title":"Analgesic potency of normorphine in patients with postoperative pain","volume":"124","author":"Lasagna","year":"1958","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"8691","key":"10.1016\/j.jflm.2018.12.005_bib81","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/0140-6736(90)90840-2","article-title":"Normorphine, a neurotoxic metabolite?","volume":"335","author":"Glare","year":"1990","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.jflm.2018.12.005_bib82","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/jat\/20.7.541","article-title":"Urine and plasma pharmacokinetics of codeine in healthy volunteers: implications for drugs-of-abuse testing","volume":"20","author":"Lafolie","year":"1996","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib83","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jchromb.2004.03.072","article-title":"Validated assay for the determination of markers of illicit heroin in urine samples for the control of patients in a heroin prescription program","volume":"811","author":"Musshoff","year":"2004","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/13556210120056553","article-title":"Diamorphine treatment for opiate dependence: putative markers of concomitant heroin misuse","volume":"6","author":"McLachlan-Troup","year":"2001","journal-title":"Addict Biol"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib85","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/dta.2244","article-title":"Confirmation of recent heroin abuse: accepting the challenge","volume":"10","author":"Maas","year":"2018","journal-title":"Drug Test Anal"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib86","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0378-4347(95)00148-C","article-title":"Separation and detection of acidic and neutral impurities in illicit heroin via capillary electrophoresis","volume":"669","author":"Lurie","year":"1995","journal-title":"J Chromatogr B Biomed Appl"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0379-0738(99)00201-7","article-title":"Noscapine as an adulterant in illicit heroin samples","volume":"108","author":"Klemenc","year":"2000","journal-title":"Forensic Sci Int"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/jat\/16.2.72","article-title":"Forensic drug testing for opiates. IV. Analytical sensitivity, specificity, and accuracy of commercial urine opiate immunoassays","volume":"16","author":"Cone","year":"1992","journal-title":"J Anal Toxicol"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib89","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jat\/17.3.156","article-title":"Forensic drug testing for opiates. V. Urine testing for heroin, morphine, and codeine with commercial opiate immunoassays","volume":"17","author":"Cone","year":"1993","journal-title":"J Anal Toxicol"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib90","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jat\/20.6.379","article-title":"Forensic drug testing for opiates. VII. Urinary excretion profile of intranasal (snorted) heroin","volume":"20","author":"Cone","year":"1996","journal-title":"J Anal Toxicol"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib91","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/cpt1971125806","article-title":"Actions and metabolism of heroin administered by continuous intravenous infusion to man","volume":"12","author":"Elliott","year":"1971","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib92","first-page":"42","article-title":"Guidelines for collection of biological samples for clinical and forensic toxicological analysis","volume":"1","author":"Dinis-Oliveira","year":"2016","journal-title":"Foren Sci Res"},{"key":"10.1016\/j.jflm.2018.12.005_bib93","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.forsciint.2018.06.041","article-title":"Can measurements of heroin metabolites in post-mortem matrices other than peripheral blood indicate if death was rapid or delayed?","volume":"290","author":"Thaulow","year":"2018","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib94","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.forsciint.2013.01.002","article-title":"Distribution of opiates in femoral blood and vitreous humour in heroin\/morphine-related deaths","volume":"226","author":"Rees","year":"2013","journal-title":"Forensic Sci Int"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib95","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/jat\/23.3.168","article-title":"Detection of 6-acetylmorphine in vitreous humor and cerebrospinal fluid--comparison with urinary analysis for proving heroin administration in opiate fatalities","volume":"23","author":"Pragst","year":"1999","journal-title":"J Anal Toxicol"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib96","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/jat\/21.6.427","article-title":"Simultaneous determination of acetylcodeine, monoacetylmorphine, and other opiates in urine by GC-MS","volume":"21","author":"O'Neal","year":"1997","journal-title":"J Anal Toxicol"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0379-0738(98)00074-7","article-title":"The detection of acetylcodeine and 6-acetylmorphine in opiate positive urines","volume":"95","author":"O'Neal","year":"1998","journal-title":"Forensic Sci Int"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib98","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/jat\/25.6.431","article-title":"Detection of non-prescription heroin markers in urine with liquid chromatography-atmospheric pressure chemical ionization mass spectrometry","volume":"25","author":"Bogusz","year":"2001","journal-title":"J Anal Toxicol"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib99","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/jat\/16.5.315","article-title":"A simplified procedure for the determination of free codeine, free morphine, and 6-acetylmorphine in urine","volume":"16","author":"Fuller","year":"1992","journal-title":"J Anal Toxicol"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib100","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jat\/26.8.561","article-title":"Acetylcodeine as a urinary marker to differentiate the use of street heroin and pharmaceutical heroin","volume":"26","author":"Brenneisen","year":"2002","journal-title":"J Anal Toxicol"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib101","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jat\/19.6.359","article-title":"Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma","volume":"19","author":"Jenkins","year":"1995","journal-title":"J Anal Toxicol"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib102","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jat\/17.6.327","article-title":"Pharmacokinetics and pharmacodynamics of intranasal \"snorted\" heroin","volume":"17","author":"Cone","year":"1993","journal-title":"J Anal Toxicol"},{"issue":"7","key":"10.1016\/j.jflm.2018.12.005_bib103","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1093\/jat\/25.7.504","article-title":"Urinary excretion profiles for total morphine, free morphine, and 6-acetylmorphine following smoked and intravenous heroin","volume":"25","author":"Smith","year":"2001","journal-title":"J Anal Toxicol"},{"issue":"2-3","key":"10.1016\/j.jflm.2018.12.005_bib104","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0379-0738(94)90228-3","article-title":"Impurities, adulterants and diluents of illicit heroin. Changes during a 12-year period","volume":"64","author":"Kaa","year":"1994","journal-title":"Forensic Sci Int"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib105","doi-asserted-by":"crossref","first-page":"980","DOI":"10.3109\/10826084.2010.540624","article-title":"Switching from methadone to diamorphine: 2-year results of the German heroin-assisted treatment trial","volume":"46","author":"Verthein","year":"2011","journal-title":"Subst Use Misuse"},{"issue":"7","key":"10.1016\/j.jflm.2018.12.005_bib106","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/0706743716673966","article-title":"Supervised injectable heroin: a clinical perspective","volume":"62","author":"Bell","year":"2017","journal-title":"Can J Psychiatr"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib107","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1192\/bjp.bp.114.149195","article-title":"Heroin on trial: systematic review and meta-analysis of randomised trials of diamorphine-prescribing as treatment for refractory heroin addictiondagger","volume":"207","author":"Strang","year":"2015","journal-title":"Br J Psychiatry"},{"issue":"7","key":"10.1016\/j.jflm.2018.12.005_bib108","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3109\/00498257509056112","article-title":"Metabolism of papaverine. II. Species differences","volume":"5","author":"Belpaire","year":"1975","journal-title":"Xenobiotica"},{"issue":"7","key":"10.1016\/j.jflm.2018.12.005_bib109","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3109\/00498257509056111","article-title":"Metabolism of papaverine. I. Identification of metabolites in rat bile","volume":"5","author":"Belpaire","year":"1975","journal-title":"Xenobiotica"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3109\/00498257809060953","article-title":"Metabolism of papaverine IV. Urinary elimination of papaverine metabolites in man","volume":"8","author":"Belpaire","year":"1978","journal-title":"Xenobiotica"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib111","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00007691-200608000-00011","article-title":"The significance of putative urinary markers of illicit heroin use after consumption of poppy seed products","volume":"28","author":"Trafkowski","year":"2006","journal-title":"Ther Drug Monit"},{"issue":"90","key":"10.1016\/j.jflm.2018.12.005_bib112","first-page":"6","article-title":"Short history of erectile dysfunction treatment","volume":"2","author":"Wisard","year":"2006","journal-title":"Rev Med Suisse"},{"issue":"9","key":"10.1016\/j.jflm.2018.12.005_bib113","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/BF03008345","article-title":"The use of muscle relaxants in the intensive care unit","volume":"39","author":"Sharpe","year":"1992","journal-title":"Can J Anaesth"},{"issue":"11-12","key":"10.1016\/j.jflm.2018.12.005_bib114","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.phytochem.2010.04.022","article-title":"The biosynthesis of papaverine proceeds via (S)-reticuline","volume":"71","author":"Han","year":"2010","journal-title":"Phytochemistry"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib115","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/jat\/bks099","article-title":"Biomarkers for illicit heroin: a previously unrecognized origin of papaverine","volume":"37","author":"Seetohul","year":"2013","journal-title":"J Anal Toxicol"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib116","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/dta.1590","article-title":"The poppy seed defense: a novel solution","volume":"6","author":"Chen","year":"2014","journal-title":"Drug Test Anal"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib117","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/dta.2058","article-title":"Urinary excretion study following consumption of various poppy seed products and investigation of the new potential street heroin marker ATM4G","volume":"9","author":"Maas","year":"2017","journal-title":"Drug Test Anal"},{"issue":"11","key":"10.1016\/j.jflm.2018.12.005_bib118","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/jnr.23109","article-title":"(1) H-nuclear magnetic resonance-based metabonomic analysis of brain in rhesus monkeys with morphine treatment and withdrawal intervention","volume":"90","author":"Deng","year":"2012","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib119","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2012.02.026","article-title":"(1)H NMR-based metabonomic analysis of brain in rats of morphine dependence and withdrawal intervention","volume":"231","author":"Hu","year":"2012","journal-title":"Behav Brain Res"},{"issue":"4S suppl l","key":"10.1016\/j.jflm.2018.12.005_bib120","article-title":"Glutamate as a neurotransmitter in the brain: review of physiology and pathology","volume":"130","author":"Meldrum","year":"2000","journal-title":"J Nutr"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib121","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/j.1471-4159.2010.07043.x","article-title":"GAD65 is essential for synthesis of GABA destined for tonic inhibition regulating epileptiform activity","volume":"115","author":"Walls","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.jflm.2018.12.005_bib122","first-page":"163","volume":"vol. 148","author":"Kuriyama","year":"1978"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib123","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1523\/JNEUROSCI.16-08-02605.1996","article-title":"The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain","volume":"16","author":"Westerink","year":"1996","journal-title":"J Neurosci"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib124","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0014-2999(96)00642-5","article-title":"Activation of ventral tegmental GABAB receptors inhibits morphine-induced place preference in rats","volume":"313","author":"Tsuji","year":"1996","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.76.1","article-title":"The role of glutamate in physical dependence on opioids","volume":"76","author":"Zhu","year":"1998","journal-title":"Jpn J Pharmacol"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib126","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0163-7258(03)00052-4","article-title":"Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress","volume":"99","author":"Brown","year":"2003","journal-title":"Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib127","doi-asserted-by":"crossref","first-page":"292","DOI":"10.4103\/psychiatry.IndianJPsychiatry_381_17","article-title":"Efficacy of buprenorphine and clonidine in opioid detoxification: a hospital- based study","volume":"60","author":"Jain","year":"2018","journal-title":"Indian J Psychiatr"},{"key":"10.1016\/j.jflm.2018.12.005_bib128","first-page":"Cd002021","article-title":"Opioid antagonists with minimal sedation for opioid withdrawal","volume":"5","author":"Gowing","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"issue":"2-3","key":"10.1016\/j.jflm.2018.12.005_bib129","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejphar.2003.10.037","article-title":"Neurochemical changes of the extracellular concentrations of glutamate and aspartate in the nucleus accumbens of rats after chronic administration of morphine","volume":"483","author":"Sepulveda","year":"2004","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.jflm.2018.12.005_bib130","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/01.WCB.0000081369.51727.6F","article-title":"Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis","volume":"23","author":"Chih","year":"2003","journal-title":"J Cerebr Blood Flow Metabol"},{"issue":"4-5","key":"10.1016\/j.jflm.2018.12.005_bib131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0197-0186(03)00020-2","article-title":"Lactate as a pivotal element in neuron-glia metabolic cooperation","volume":"43","author":"Pellerin","year":"2003","journal-title":"Neurochem Int"},{"issue":"1-2","key":"10.1016\/j.jflm.2018.12.005_bib132","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuint.2007.06.016","article-title":"Oxidative stress on the astrocytes in culture derived from a senescence accelerated mouse strain","volume":"52","author":"Lu","year":"2008","journal-title":"Neurochem Int"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087040","article-title":"Mechanisms of metabonomic for a gateway drug: nicotine priming enhances behavioral response to cocaine with modification in energy metabolism and neurotransmitter level","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib134","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bbagen.2007.09.018","article-title":"Differential effect of creatine on oxidatively-injured mitochondrial and nuclear DNA","volume":"1780","author":"Guidi","year":"2008","journal-title":"Biochim Biophys Acta"},{"issue":"21","key":"10.1016\/j.jflm.2018.12.005_bib135","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1523\/JNEUROSCI.19-21-09459.1999","article-title":"Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism","volume":"19","author":"El Idrissi","year":"1999","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib136","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jnr.10027","article-title":"Role of taurine in regulation of intracellular calcium level and neuroprotective function in cultured neurons","volume":"66","author":"Chen","year":"2001","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib137","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00726-004-0066-8","article-title":"Taurine restores ethanol-induced depletion of antioxidants and attenuates oxidative stress in rat tissues","volume":"27","author":"Pushpakiran","year":"2004","journal-title":"Amino Acids"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib138","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00726-006-0396-9","article-title":"Taurine increases mitochondrial buffering of calcium: role in neuroprotection","volume":"34","author":"El Idrissi","year":"2008","journal-title":"Amino Acids"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib139","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s00726-006-0405-z","article-title":"Taurine reduces caspase-8 and caspase-9 expression induced by ischemia in the mouse hypothalamic nuclei","volume":"34","author":"Taranukhin","year":"2008","journal-title":"Amino Acids"},{"issue":"7","key":"10.1016\/j.jflm.2018.12.005_bib140","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/BF01973715","article-title":"Taurine, a possible urinary marker of liver damage: a study of taurine excretion in carbon tetrachloride-treated rats","volume":"65","author":"Waterfield","year":"1991","journal-title":"Arch Toxicol"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib141","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/BF00638929","article-title":"Use of urinary taurine and creatine as biomarkers of organ dysfunction and metabolic perturbations","volume":"5","author":"Timbrell","year":"1995","journal-title":"Comparat Haematol Internat"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib142","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s004240000247","article-title":"The involvement of caspases in the CD95(Fas\/Apo-1)- but not swelling-induced cellular taurine release from Jurkat T-lymphocytes","volume":"440","author":"Lang","year":"2000","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib143","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s004249900168","article-title":"Release of taurine in apoptotic cerebellar granule neurons in culture","volume":"439","author":"Moran","year":"2000","journal-title":"Pfl\u00fcgers Archiv"},{"issue":"Pt 2","key":"10.1016\/j.jflm.2018.12.005_bib144","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1113\/jphysiol.2005.087130","article-title":"Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts","volume":"567","author":"Friis","year":"2005","journal-title":"J Physiol"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib145","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/01926230290105820","article-title":"Invited review: cell volume control and signal transduction in apoptosis","volume":"30","author":"G\u00f3mez-Angelats","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.jflm.2018.12.005_bib146","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.aca.2011.09.033","article-title":"Morphine-induced conditioned place preference in mice: metabolomic profiling of brain tissue to find \"molecular switch\" of drug abuse by gas chromatography\/mass spectrometry","volume":"710","author":"Meng","year":"2012","journal-title":"Anal Chim Acta"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib147","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.molbrainres.2004.09.018","article-title":"Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains","volume":"133","author":"Kim","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib148","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/omi.2008.0061","article-title":"Metabonomic profile of rats with acute liver rejection","volume":"13","author":"Wu","year":"2009","journal-title":"Omics"},{"issue":"7","key":"10.1016\/j.jflm.2018.12.005_bib149","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s11064-008-9895-2","article-title":"Glial metabolism of valine","volume":"34","author":"Murin","year":"2009","journal-title":"Neurochem Res"},{"issue":"52","key":"10.1016\/j.jflm.2018.12.005_bib150","doi-asserted-by":"crossref","first-page":"42508","DOI":"10.1074\/jbc.M507380200","article-title":"High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease","volume":"280","author":"Pears","year":"2005","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib151","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF02527761","article-title":"Metabolism of N-acetyl-L-aspartate in rat brain","volume":"21","author":"Miller","year":"1996","journal-title":"Neurochem Res"},{"issue":"17","key":"10.1016\/j.jflm.2018.12.005_bib152","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/j.febslet.2008.06.040","article-title":"Metabolic profiling reveals disorder of amino acid metabolism in four brain regions from a rat model of chronic unpredictable mild stress","volume":"582","author":"Ni","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jflm.2018.12.005_bib153","first-page":"269","article-title":"Cingulate metabolites during pain and morphine treatment as assessed by magnetic resonance spectroscopy","volume":"7","author":"Hansen","year":"2014","journal-title":"J Pain Res"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib154","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/BF00971582","article-title":"Osmotic regulation of myo-inositol uptake in primary astrocyte cultures","volume":"19","author":"Isaacks","year":"1994","journal-title":"Neurochem Res"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib155","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","article-title":"Metabolic characterization of the R6\/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy","volume":"5","author":"Tsang","year":"2006","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib156","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/glia.440120105","article-title":"Osmoregulatory changes in myo-inositol content and Na+\/myo-inositol cotransport in rat cortical astrocytes","volume":"12","author":"Strange","year":"1994","journal-title":"Glia"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib157","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1176\/ajp.156.5.716","article-title":"Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine users","volume":"156","author":"Chang","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib158","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.neuint.2006.09.012","article-title":"Metabolic changes in rat prefrontal cortex and hippocampus induced by chronic morphine treatment studied ex vivo by high resolution 1H NMR spectroscopy","volume":"50","author":"Gao","year":"2007","journal-title":"Neurochem Int"},{"issue":"48","key":"10.1016\/j.jflm.2018.12.005_bib159","doi-asserted-by":"crossref","first-page":"20620","DOI":"10.1073\/pnas.1001111107","article-title":"Asymmetric phosphorylation through catalytic P(III) phosphoramidite transfer: enantioselective synthesis of D-myo-inositol-6-phosphate","volume":"107","author":"Jordan","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"47","key":"10.1016\/j.jflm.2018.12.005_bib160","doi-asserted-by":"crossref","first-page":"15370","DOI":"10.1021\/ja047360x","article-title":"Chemistry and biology of deoxy-myo-inositol phosphates: stereospecificity of substrate interactions within an archaeal and a bacterial IMPase","volume":"126","author":"Morgan","year":"2004","journal-title":"J Am Chem Soc"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib161","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1046\/j.1460-9568.1999.00624.x","article-title":"Stimulation of mu- and delta-opioid receptors enhances phosphoinositide metabolism in mouse spinal cord: evidence for subtypes of delta-receptors","volume":"11","author":"Sanchez-Blazquez","year":"1999","journal-title":"Eur J Neurosci"},{"issue":"9","key":"10.1016\/j.jflm.2018.12.005_bib162","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1023\/A:1024996415795","article-title":"Alterations in brain metabolism induced by chronic morphine treatment: NMR studies in rat CNS","volume":"28","author":"Sharma","year":"2003","journal-title":"Neurochem Res"},{"issue":"1-2","key":"10.1016\/j.jflm.2018.12.005_bib163","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.brainres.2005.05.053","article-title":"Succinate causes oxidative damage through N-methyl-D-aspartate-mediated mechanisms","volume":"1051","author":"Sinhorin","year":"2005","journal-title":"Brain Res"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib164","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.neuroscience.2004.01.058","article-title":"Succinate increases neuronal post-synaptic excitatory potentials in vitro and induces convulsive behavior through N-methyl-d-aspartate-mediated mechanisms","volume":"125","author":"Roehrs","year":"2004","journal-title":"Neuroscience"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib165","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00216-013-7234-1","article-title":"Metabolic profiling of urine and blood plasma in rat models of drug addiction on the basis of morphine, methamphetamine, and cocaine-induced conditioned place preference","volume":"406","author":"Zaitsu","year":"2014","journal-title":"Anal Bioanal Chem"},{"issue":"45","key":"10.1016\/j.jflm.2018.12.005_bib166","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","article-title":"Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau","volume":"28","author":"Green","year":"2008","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib167","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00221-009-2103-z","article-title":"Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats","volume":"202","author":"Morales","year":"2010","journal-title":"Exp Brain Res"},{"issue":"1-3","key":"10.1016\/j.jflm.2018.12.005_bib168","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2012.06.031","article-title":"Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse","volume":"127","author":"Zheng","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jflm.2018.12.005_bib169","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2121-10-54","article-title":"Evaluation of expression and function of the H+\/myo-inositol transporter HMIT","volume":"10","author":"Di Daniel","year":"2009","journal-title":"BMC Cell Biol"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0893-133X(00)00209-8","article-title":"Striatal dopaminergic and serotonergic markers in human heroin users","volume":"24","author":"Kish","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.jflm.2018.12.005_bib171","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.drugalcdep.2012.06.031","article-title":"Metabolic phenotype of rats exposed to heroin and potential markers of heroin abuse","volume":"127","author":"Zheng","year":"2013","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib172","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.dmpk.2016.10.410","article-title":"Metabolomic profiling of brain tissues of mice chronically exposed to heroin","volume":"32","author":"Li","year":"2017","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib173","first-page":"41","article-title":"Biochemical mechanism studies of venlafaxine by metabonomic method in rat model of depression","volume":"17","author":"Fenli","year":"2013","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib174","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S0022-5347(25)00317-9","article-title":"Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain","volume":"241","author":"Commins","year":"1987","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"7","key":"10.1016\/j.jflm.2018.12.005_bib175","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s11064-012-0739-8","article-title":"Dynamic changes of tyrosine hydroxylase and dopamine concentrations in the ventral tegmental area-nucleus accumbens projection during the expression of morphine-induced conditioned place preference in rats","volume":"37","author":"Liang","year":"2012","journal-title":"Neurochem Res"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib176","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1471-4159.1991.tb02133.x","article-title":"Morphine and cocaine exert common chronic actions on tyrosine hydroxylase in dopaminergic brain reward regions","volume":"57","author":"Beitner-Johnson","year":"1991","journal-title":"J Neurochem"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib177","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00213-010-2072-8","article-title":"Reciprocal responsiveness of nucleus accumbens shell and core dopamine to food- and drug-conditioned stimuli","volume":"214","author":"Bassareo","year":"2011","journal-title":"Psychopharmacology (Berlin)"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib178","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/20961790.2017.1285219","article-title":"Metabolism and metabolomics of ketamine: a toxicological approach","volume":"2","author":"Dinis-Oliveira","year":"2017","journal-title":"Forensic Sci Res"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib179","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1365-2044.1993.tb06785.x","article-title":"Histamine release by morphine and diamorphine in man","volume":"48","author":"Withington","year":"1993","journal-title":"Anaesthesia"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib180","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/nar\/gkv047","article-title":"Regulation of mammalian nucleotide metabolism and biosynthesis","volume":"43","author":"Lane","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib181","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12011-010-8634-0","article-title":"Antioxidant enzyme and element status in heroin addiction or heroin withdrawal in rats: effect of melatonin and vitamin E plus Se","volume":"139","author":"Cemek","year":"2011","journal-title":"Biol Trace Elem Res"},{"issue":"7109","key":"10.1016\/j.jflm.2018.12.005_bib182","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nature05026","article-title":"Central nervous system control of food intake and body weight","volume":"443","author":"Morton","year":"2006","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.jflm.2018.12.005_bib183","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199503093321001","article-title":"Changes in energy expenditure resulting from altered body weight","volume":"332","author":"Leibel","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib184","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12868-018-0404-5","article-title":"Metabolomics analysis of serum in a rat heroin self-administration model undergoing reinforcement based on (1)H-nuclear magnetic resonance spectra","volume":"19","author":"Ning","year":"2018","journal-title":"BMC Neurosci"},{"issue":"12","key":"10.1016\/j.jflm.2018.12.005_bib185","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/j.1360-0443.2007.02011.x","article-title":"Self-administration of drugs in animals and humans as a model and an investigative tool","volume":"102","author":"Panlilio","year":"2007","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib186","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10545-005-5518-0","article-title":"Cerebral ketone body metabolism","volume":"28","author":"Morris","year":"2005","journal-title":"J Inherit Metab Dis"},{"issue":"10","key":"10.1016\/j.jflm.2018.12.005_bib187","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMra023160","article-title":"Drug addiction","volume":"349","author":"Cami","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib188","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.neuroscience.2006.11.013","article-title":"Role of acetylcholine transmission in nucleus accumbens and ventral tegmental area in heroin-seeking induced by conditioned cues","volume":"144","author":"Zhou","year":"2007","journal-title":"Neuroscience"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib189","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hup.1068","article-title":"Opioid use affects antioxidant activity and purine metabolism: preliminary results","volume":"24","author":"Mannelli","year":"2009","journal-title":"Hum Psychopharmacol"},{"issue":"13","key":"10.1016\/j.jflm.2018.12.005_bib190","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1021\/ac060209g","article-title":"Targeted profiling: quantitative analysis of 1H NMR metabolomics data","volume":"78","author":"Weljie","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.jflm.2018.12.005_bib191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trac.2011.08.009","article-title":"Metabolite identification and quantitation in LC-MS\/MS-based metabolomics","volume":"32","author":"Xiao","year":"2012","journal-title":"Trends Anal Chem"},{"key":"10.1016\/j.jflm.2018.12.005_bib192","first-page":"92","volume":"vol. 1","author":"Worley","year":"2013"},{"key":"10.1016\/j.jflm.2018.12.005_bib193","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-1-4939-2377-9_3","article-title":"NMR spectroscopy of biofluids and extracts","volume":"1277","author":"Le Gall","year":"2015","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jflm.2018.12.005_bib194","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jpba.2016.07.008","article-title":"Metabolomics studies in brain tissue: a review","volume":"130","author":"Gonzalez-Riano","year":"2016","journal-title":"J Pharmaceut Biomed Anal"},{"key":"10.1016\/j.jflm.2018.12.005_bib195","first-page":"1","article-title":"Untargeted metabolomics","author":"Vinayavekhin","year":"2010","journal-title":"Curr Protoc Mol Biol"},{"key":"10.1016\/j.jflm.2018.12.005_bib196","first-page":"1","article-title":"Targeted metabolomics","author":"Roberts","year":"2012","journal-title":"Curr Protoc Mol Biol"},{"issue":"10","key":"10.1016\/j.jflm.2018.12.005_bib197","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/rcm.4015","article-title":"High-resolution extracted ion chromatography, a new tool for metabolomics and lipidomics using a second-generation orbitrap mass spectrometer","volume":"23","author":"Koulman","year":"2009","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib198","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nmeth.3393","article-title":"MS-DIAL: data-independent MS\/MS deconvolution for comprehensive metabolome analysis","volume":"12","author":"Tsugawa","year":"2015","journal-title":"Nat Methods"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib199","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/s11306-014-0734-y","article-title":"MarVis-Pathway: integrative and exploratory pathway analysis of non-targeted metabolomics data","volume":"11","author":"Kaever","year":"2015","journal-title":"Metabolomics"},{"issue":"9","key":"10.1016\/j.jflm.2018.12.005_bib200","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1021\/ac802689c","article-title":"MetaboliteDetector: comprehensive analysis tool for targeted and nontargeted GC\/MS based metabolome analysis","volume":"81","author":"Hiller","year":"2009","journal-title":"Anal Chem"},{"key":"10.1016\/j.jflm.2018.12.005_bib201","doi-asserted-by":"crossref","DOI":"10.5936\/csbj.201301009","article-title":"Statistical methods for the analysis of high-throughput metabolomics data","volume":"4","author":"Bartel","year":"2013","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"10.1016\/j.jflm.2018.12.005_bib202","first-page":"92","article-title":"Multivariate analysis in metabolomics","volume":"1","author":"Worley","year":"2013","journal-title":"Current Metabolomics"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib203","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabonomics: a platform for studying drug toxicity and gene function","volume":"1","author":"Nicholson","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib204","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/nbm.935","article-title":"NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition","volume":"18","author":"Bollard","year":"2005","journal-title":"NMR Biomed"},{"issue":"1-3","key":"10.1016\/j.jflm.2018.12.005_bib205","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-5793(02)03476-2","article-title":"Physiological variation in metabolic phenotyping and functional genomic studies: use of orthogonal signal correction and PLS-DA","volume":"530","author":"Gavaghan","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jflm.2018.12.005_bib206","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.copbio.2018.01.008","article-title":"Advances in computational metabolomics and databases deepen the understanding of metabolisms","volume":"54","author":"Tsugawa","year":"2018","journal-title":"Curr Opin Biotechnol"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib207","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bmhimx.2017.03.003","article-title":"Omics-based biomarkers: current status and potential use in the clinic","volume":"74","author":"Quezada","year":"2017","journal-title":"Bol M\u00e9dico Hosp Infant M\u00e9xico"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib208","doi-asserted-by":"crossref","first-page":"755","DOI":"10.20344\/amp.5215","article-title":"Licit and ilicit uses of medicines","volume":"27","author":"Dinis-Oliveira","year":"2014","journal-title":"Acta Med Port"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib209","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1080\/03602532.2016.1192642","article-title":"Metabolomics of methadone: clinical and forensic toxicological implications and variability of dose response","volume":"48","author":"Dinis-Oliveira","year":"2016","journal-title":"Drug Metab Rev"},{"issue":"23","key":"10.1016\/j.jflm.2018.12.005_bib210","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.4155\/bio.14.260","article-title":"Metabolomics of drugs of abuse: a more realistic view of the toxicological complexity","volume":"6","author":"Dinis-Oliveira","year":"2014","journal-title":"Bioanalysis"},{"issue":"8","key":"10.1016\/j.jflm.2018.12.005_bib211","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1021\/acs.chemrestox.7b00126","article-title":"Street-like synthesis of krokodil results in the formation of an enlarged cluster of known and new morphinans","volume":"30","author":"Soares","year":"2017","journal-title":"Chem Res Toxicol"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib212","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/1874467210666170704110146","article-title":"Opioids in the frame of new psychoactive substances network: a complex pharmacological and toxicological issue","volume":"11","author":"Ventura","year":"2018","journal-title":"Curr Mol Pharmacol"},{"issue":"2","key":"10.1016\/j.jflm.2018.12.005_bib213","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.taap.2010.09.022","article-title":"The enhanced value of combining conventional and \"omics\" analyses in early assessment of drug-induced hepatobiliary injury","volume":"252","author":"Ellinger-Ziegelbauer","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"10.1016\/j.jflm.2018.12.005_bib214","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1021\/pr060649o","article-title":"Proteomic analysis of rat prefrontal cortex in three phases of morphine-induced conditioned place preference","volume":"6","author":"Yang","year":"2007","journal-title":"J Proteome Res"},{"issue":"18","key":"10.1016\/j.jflm.2018.12.005_bib215","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1021\/ac0708588","article-title":"Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles","volume":"79","author":"Slupsky","year":"2007","journal-title":"Anal Chem"},{"key":"10.1016\/j.jflm.2018.12.005_bib216","article-title":"Metabolomics technology and bioinformatics for precision medicine","author":"Azad","year":"2018","journal-title":"Briefings Bioinf"},{"issue":"5","key":"10.1016\/j.jflm.2018.12.005_bib217","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/ije\/dyw046","article-title":"Metabolomics in epidemiology: from metabolite concentrations to integrative reaction networks","volume":"45","author":"Fearnley","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.jflm.2018.12.005_bib218","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.tibs.2017.01.004","article-title":"Metabolomics: a primer","volume":"42","author":"Liu","year":"2017","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"10.1016\/j.jflm.2018.12.005_bib219","first-page":"256","article-title":"Cancer biomarker discovery and validation","volume":"4","author":"Goossens","year":"2015","journal-title":"Transl Cancer Res"}],"container-title":["Journal of Forensic and Legal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X18302506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1752928X18302506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T00:13:42Z","timestamp":1761696822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1752928X18302506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":219,"alternative-id":["S1752928X18302506"],"URL":"https:\/\/doi.org\/10.1016\/j.jflm.2018.12.005","relation":{},"ISSN":["1752-928X"],"issn-type":[{"value":"1752-928X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism and metabolomics of opiates: A long way of forensic implications to unravel","name":"articletitle","label":"Article Title"},{"value":"Journal of Forensic and Legal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jflm.2018.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd and Faculty of Forensic and Legal Medicine. All rights reserved.","name":"copyright","label":"Copyright"}]}}